Compare State Street SPDR S&P Biotech ETF (XBI) vs Xpeng Inc - ADR (XPEV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
State Street SPDR S&P Biotech ETF vs Xpeng Inc - ADR — how do they compare? State Street SPDR S&P Biotech ETF trades at $154.49, while Xpeng Inc - ADR trades at $13.38 (market cap $12.96B). The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Xpeng Inc - ADR nearer its low. Which is the better fit depends on your goals.
| XBI | XPEV | |
|---|---|---|
Sector | Broad Market / Factor | Consumer Cyclical |
52-Week High | $164.28 | $28.07 |
52-Week Low | $85.16 | $12.09 |
Market Cap | — | $12.96B |
Enterprise Value | — | $15.07B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →About Xpeng Inc - ADR
Founded in 2015, XPeng is a leading Chinese smart electric vehicle, or EV, company that designs, develops, manufactures and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 98,000 EVs in 2021, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
Read more on XPEV →
